Guido Oerker
CEO
Replay available
Swedish Orphan Biovitrum AB (SOBI) Q1 2026 Earnings Call
Swedish Orphan Biovitrum AB (STO: SOBI) Q1 2026 earnings conference call, held 2026-04-28. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lydia Bart-Franzsch
Head of R&D and Chief Medical Officer
Henrik Stenqvist
CFO
Shirley Chen
Analyst, Barclays
Christopher Yudi
Analyst, SEB
Kirstie Ross-Stewart
Analyst, BNP Paribas
Matthias Heikblom
Analyst, Handelsbanken
Harry Gellies
Analyst, Berenberg
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Swedish Orphan Biovitrum Ab.
Replay transcript excerpt
WEBVTT 00:00:00.166 -- 00:00:04.372 Hello, everyone. This is Guido Oerker, CEO of Sobe. 00:00:04.372 -- 00:00:09.499 We are delighted to welcome you to the first quarter 2026 conference call 00:00:09.499 -- 00:00:12.122 for investors and analysts. 00:00:12.122 -- 00:00:16.308 Our presentation was posted on Sobe.com earlier today. 00:00:16.308 -- 00:00:21.816 Please turn to the next slide. We would like to remind you of the usual provisions 00:00:21.816 -- 00:00:25.541 on statements about expectations and projections 00:00:25.541 -- 00:00:30.627 of future events. unless stated otherwise, we are making comments that 00:00:30.627 -- 00:00:35.632 most relate to the first quarter at constant exchange rates in 00:00:35.632 -- 00:00:40.197 million Swedish krona. Please turn to the next slide. 00:00:40.197 -- 00:00:45.143 Today, we plan to cover the key aspects of our Q1 report. 00:00:45.143 -- 00:00:50.468 I'm joined by Henrik Stenqvist, our CFO, and Lydia Bart-Franzsch, head of R&D 00:00:50.468 -- 00:00:55.814 and chief medical officer. We plan to review the presentation first and then have 00:00:55.814 -- 00:01:00.839 a Q&A until around 1.30 p.m. Central Eastern 00:01:00.839 -- 00:01:06.146 European Time. For those on the phone, please join the queue for questions 00:01:06.146 -- 00:01:11.732 by pressing star one. We propose that you ask only one, 00:01:11.732 -- 00:01:17.857 maximum two questions at a time. Please turn to the next slide. 00:01:18.460 -- 00:01:24.805 We have delivered a very strong start in Q1 2026, 00:01:25.008 -- 00:01:30.127 operationally and financially, with 24% revenue growth at 00:01:30.127 -- 00:01:36.051 constant exchange rate and an adjusted EBITDA at 38%. 00:01:36.413 -- 00:01:40.094 Reflecting strong commercial execution 00:01:40.316 -- 00:01:...